GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Collplant Biotechnologies CLGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.29

+8.06%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Collplant Biotechnologies

Our reporting

Next results

25 Nov 2026

Due on 25 Nov 2026.

Past results

Reported against what analysts expected

30 Sept 202623 Sept 202619 Aug 202629 May 202626 Mar 202626 Nov 2025
Earnings per share-1.89-2.80-0.28-0.23-0.26-0.27
Forecast-2.45——-0.24-0.300.38
Revenue$108,000——$73,000$60,000$77,000
Forecast$480,000——$460,000$2.1m$6.8m

Key events

  1. 4 Sept 202610-to-1 reverse split
  2. 21 Nov 20163-to-2 reverse split
  3. 1 Sept 1993Listed

Collplant Biotechnologies in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.